方法文章

Visualization of Protein-protein Interaction in Nuclear and Cytoplasmic Fractions by Co-immunoprecipitation and In Situ Proximity Ligation Assay

DOI:

10.3791/55218

2017年1月16日

本文内容

摘要

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

蛋白质-蛋白质相互作用可以发生在细胞核和细胞质中。为了研究这些相互作用,应用了传统的免疫共沉淀和现代邻位连接测定。在这项研究中,我们比较了这两种方法,以可视化 NF90-RBM3 相互作用在细胞核和细胞质中的分布。

摘要

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

蛋白质-蛋白质相互作用涉及数千个细胞过程,并发生在不同的空间环境中。传统上,免疫共沉淀是一种检测蛋白质-蛋白质相互作用的常用技术。随后的 Western blot 分析是可视化免疫共沉淀蛋白的最常用方法。最近,邻位连接测定已成为原位可视化蛋白质-蛋白质相互作用的强大工具,并为通过这种方法量化蛋白质-蛋白质相互作用提供了可能性。与传统免疫细胞化学类似,邻位连接测定技术也基于一抗对抗原的可及性,但相比之下,邻位连接测定使用涉及滚环 PCR 的独特技术检测蛋白质-蛋白质相互作用,而常规免疫细胞化学仅显示蛋白质的共定位。

核因子 90 (NF90) 和 RNA 结合基序蛋白 3 (RBM3) 先前已被证明是相互作用的伙伴。它们主要位于细胞核中,但也迁移到细胞质中并调节细胞质中的信号通路。在这里,我们通过免疫共沉淀和邻位连接测定比较了细胞核和细胞质中 NF90-RBM3 的相互作用。此外,我们讨论了这两种技术在可视化蛋白质-蛋白质相互作用方面在空间分布和蛋白质-蛋白质相互作用特性方面的优势和局限性。

引言

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Nuclear factor 90 (NF90) is a multi-isoform protein with numerous functions including the response to viral infection, regulation of interleukin-2 post-transcription and regulation of miRNA biogenesis 1-3. RBM3 is an RNA-binding protein, involved in translation and miRNA biogenesis and can be induced by various stressors including hypothermia and hypoxia 4-6. Recently, we found NF90 and RBM3 in a protein complex 7. The interaction of NF90 and RBM3 is essential to modulate protein kinase RNA-like endoplasmic reticulum kinase (PERK) activity in unfolded protein response 7. Both NF90 and RBM3 are located predominantly in the nucleus but a small proportion of NF90 and RBM3 shuttle into the cytoplasm and bind there to each other for specific functions, e.g. to regulate PERK activity. Therefore, it is important to visualize the distribution of NF90-RBM3 interactions in the subcellular compartment, which may indicate their various roles in respective compartment.

Decades ago, yeast two hybrid (Y2H) was developed to detect the interaction between two proteins 8. However, due to artificial construction of fused proteins, false positive results have restricted the application of this method. For a long time, co-immunoprecipitation was the main technique to analyze protein-protein interactions, especially in endogeneous conditions 9. To analyze the co-immunoprecipitated protein complex, Western blot is the most convenient technique, while mass spectrometry is used when super sensitivity and accuracy are desired. In recent years, proximity ligation assay has been developed as a novel method to detect protein-protein interactions in both cells and tissues in situ 10,11.

Here, we compared the most popular co-immunoprecipitation method and relatively novel proximity ligation assay method in capturing NF90-RBM3 interaction in subcellular fractions. We also discussed the advantages and limitations of both techniques.

访问受限。请登录或开始试用以查看此内容。

方案

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

1. Co-immunoprecipitation

  1. Seed HEK293 cells at 2 x 105 cells per well in one 6-well plate in 2 ml Dulbecco's Modified Eagle's Medium (DMEM) supplement with 10% fetal bovine serum (FBS) and 100 U/mL Penicillin-Streptomycin (Pen-Strep).
  2. Grow cells for 48 hr at 37 °C with 5% CO2.
  3. Wash cells with cold phosphate-buffered saline (PBS) three times. Harvest cells by centrifugation at 500 x g for 5 min at 4 °C.
  4. Prepare nuclear and cytoplasmic fractions using commercial nuclear and cytoplasmic extraction reagents. Follow manufacturer's instruction with some modifications.
    1. Use 3 x 106 cells for one co-immunoprecipitation experiment (approximately with 90% confluency from 3 wells of one 6-well plate). Add 300 µl cold cytoplasmic extraction solution (CER I) and vortex for 15 sec at the highest speed.
    2. Incubate for 30 min on ice. During incubation, vortex for 5 s every 10 min.
    3. Add 16.5 µl cold cytoplasmic extraction solution II (CER II), vortex for 5 sec and incubate for 5 min on ice.
    4. Vortex for 5 sec and centrifuge at 16,000 x g for 5 min at 4 °C.
    5. Transfer supernatant (cytoplasmic extract) into a new pre-chilled tube, and keep on ice until used.
    6. Wash insoluble pellets (containing nuclei) three times with 1 ml cold PBS each time by pipetting up and down five times. Remove PBS after wash.
    7. Add 150 µl cold nuclear extraction solution (NER), vortex for 15 sec and incubate 1 hr on ice. During incubation, vortex for 15 sec and pipette 10 times with a 200 µl tip every 10 min.
    8. Vortex for 15 s and centrifuge at 16,000 x g for 10 min at 4 °C.
    9. Transfer supernatant (nuclear extract) into a new pre-chilled tube, keep on ice until use.
  5. Take out 10% of the volume of nuclear and cytoplasmic extracts each as inputs.
  6. Add cold PBS to the remaining extracts to a final volume of 1 ml. Keep on ice until use.
    NOTE: Pre-clearing is not essential when using Protein G-conjugated magnetic beads. However, if the background is high, perform pre-clearing by incubating 40 µl Protein G-conjugated magnetic beads (50% slurry) and 1 ml diluted lysate from this step at 4 °C for 30 min on a rotator. Separate supernatant (pre-cleared lysate) from beads with magnetic rack. Discard the beads.
  7. To couple primary antibody with Protein G-conjugated magnetic beads, incubate 40 µl Protein G-conjugated magnetic beads (50% slurry) with 4 µg rabbit polyclonal anti-RBM3 antibody or rabbit IgG (negative control) in 200 µl PBS plus Tween 20 buffer (PBST, 0.02% Tween 20) at room temperature (RT) for 40 min on a rotator.
  8. Separate antibody-coupled beads and supernatant with a magnetic rack, and discard the supernatant. Wash the beads once with 200 µl PBST (0.02%).
  9. Add 1 ml diluted lysates (or if necessary, pre-cleared lysates) to the beads, and incubate on a rotator at 4 °C overnight.
  10. On the next day, separate the beads and supernatant by a magnetic rack, and discard the supernatant. Wash 3 x 10 min with 0.5 ml PBST (0.02%) for each tube at 4 °C on a rotator with a fixed speed of 20 rpm.
  11. Elute proteins from the beads by adding 40 µl sample buffer (1x commercial sample buffer and 50 mM 1,4-dithiothreitol (DTT)). Heat at 70 °C for 10 min. Spin down and transfer liquids to a new 1.5 ml tube.
  12. Dilute input lysates in sample buffer (final concentration: 1x commercial sample buffer and 50 mM DTT) and heat at 70 °C for 10 min. Load inputs and immunoprecipitated proteins from the last step to a precast 4-12% bis-Tris gel. The loading volume of each well should not exceed 20 µl. Perform electrophoresis in 1x commercial running buffer on ice for 35 min.
    NOTE: Load nuclear and cytoplasmic extracts in a ratio of 1:2 (V/V), which reflects the same initial amount of cells.
  13. Transfer proteins to PVDF membrane in 1x commercial transfer buffer at 30 V for 2 hr at 4 °C.
  14. Block membrane with 5% skimmed milk in PBST (0.1% Tween 20) at RT for 40 min on a shaker.
  15. Incubate membrane with primary antibodies (both diluted in 1:1,000) in PBST (0.1%) at 4 °C overnight.
  16. Wash 3 x 10 min with PBST (0.1%) at RT on a shaker.
  17. Incubate membrane with horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit secondary antibodies (both diluted in 1:5,000) in PBST (0.1%) at RT for 1 hr.
  18. Wash 3 x 10 min with PBST (0.1%) at RT on a shaker.
  19. Use 0.2 ml enhanced chemiluminescence (ECL) substrate mixture per cm2 membrane, incubate at RT for 5 min. Avoid all light from this step onwards except red lights.
  20. Discard liquid and expose to an X-ray film in a film cassette. Develop film using an automatic film processing machine.

2. Immunocytochemistry and Proximity Ligation Assay

  1. Seed HEK293 cells at 1.5 x 104 cells per chamber in one 8-chamber poly-D-lysine coated slide in 0.4 ml DMEM supplemented with 10% FBS and 100 U/ml Pen-Strep.
  2. Grow cells for 48 hr at 37 °C with 5% CO2.
  3. Aspirate medium, and fix cells with 4% paraformaldehyde (PFA) for 10 min at RT.
  4. Aspirate PFA, and wash 3 x 10 min with 0.5 ml PBS per chamber.
  5. Permeabilize and block cells with 0.5% Triton X-100 and 5% normal goat serum (NGS) in PBS at RT for 1 hr.
  6. Incubate with primary antibodies in 0.1% Triton X-100 and 5% NGS in PBS on a shaker at 4 °C overnight. Dilute mouse monoclonal anti-NF90 antibody and rabbit polyclonal anti-RBM3 antibody 1:100 in PBS for double-staining. For negative control, omit independently either of the two primary antibodies, and omit both antibodies in a third control.
    NOTE: Do not use commercial blocking and diluting reagents.
  7. Wash 3 x 10 min with 0.5 ml PBS per chamber.
  8. Subject to immunocytochemistry or proximity ligation assay protocols
    1. Immunocytochemistry
      1. Incubate with 1:500 diluted green fluorescent dye-coupled anti-mouse and red fluorescent dye-coupled anti-rabbit secondary antibodies at RT for 1 hr. Avoid light from this step onwards.
      2. Counterstain nuclei with 4′, 6-diamidin-2-phenylindol (DAPI) diluted 1:5,000 in PBS at RT for 10 min.
      3. Wash 3 x 10 min with 0.5 ml PBS per chamber.
      4. Remove the chambers from the glass slide and dry. Mount with 250 µ, mounting medium per slide.
    2. Proximity ligation assay
      1. Prepare proximity ligation assay probes. Mix and dilute two proximity ligation assay probes (anti-mouse and anti-rabbit secondary antibodies attached with different oligonucleotides which can ligate through the addition of two other oligonucleotides in ligation solution) both 1:5 in 0.1% Triton X-100 and 5% NGS in PBS, with a total volume of 320 µl for one 8-chamber slide (approximately 40 µl per cm2). Incubate at RT for 20 min.
      2. Remove the chambers from the glass slide and add the diluted probes. Incubate in a humidity incubator at 37 °C for 1 hr.
      3. Prepare ligation solution. Mix 8 µl ligase, 64 µl 5 x ligation stock and 248 µl H2O.
      4. Tap off the liquid from the slide, and wash 2 x 5 min in 1x Wash Buffer A (provided with the kit).
      5. Add ligation solution and incubate in a humidity incubator at 37 °C for 30 min.
      6. Prepare amplification solution. Mix 4 µl polymerase, 64 µl 5x amplification stock and 252 µl H2O. Avoid light from this step onwards.
      7. Tap off liquid from the slide, and wash 2 x 2 min in 1x Wash Buffer A.
      8. Add the amplification solution and incubate in a dark humidity incubator at 37 °C for 100 min.
      9. Tap off the liquid from the slide, and wash 2 x 10 min in 1x Wash Buffer B (provided with the kit). Wash for 1 min in 0.01x Wash Buffer B.
      10. Dry the slide and mount with 250 µl of a commercial mounting medium (with DAPI) per slide.
  9. Examine fluorescent signals under a microscope using a 10X eyepiece lens and 20X objective lens. Acquire images by a CCD camera.

访问受限。请登录或开始试用以查看此内容。

结果

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Figure 1 demonstrates that NF90 and RBM3 are both nuclear proteins and only a small fraction is present in the cytoplasm. Notably, there are three different bands stained positive for RBM3. The smallest just below 20 kDa reflects the correct size of RBM3 (the predicted molecular weight of RBM3 is 17 kDa). The origin of the two other bands remains to be investigated. Co-immunoprecipitation experiments with RBM3 as the bait protein revealed that NF90-RBM3 interactions are p...

访问受限。请登录或开始试用以查看此内容。

讨论

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

There are several benefits as well as shortcomings for both methods. As a relatively novel technique, an obvious advantage of proximity ligation assay is the feasibility to elucidate protein-protein interactions at single-cell level instead of a batch of heterogeneous cells. Images with high magnitude and resolution (e.g. by confocal microscope) provide the possibility for quantification by counting single fluorescent spots. In contrast, the conventional combination of co-immunoprecipitation technique with Weste...

访问受限。请登录或开始试用以查看此内容。

披露

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

作者没有什么可透露的。

致谢

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

这项研究得到了瑞士国家科学基金会 (SNSF, 31003A_163305) 的支持。

访问受限。请登录或开始试用以查看此内容。

材料

本文使用的材料清单
姓名公司目录编号评论
Dulbecco 的改良鹰s 培养基 (DMEM)SigmaD6429高葡萄糖
4,500 mg/L
胎牛血清 (FBS)Gibco,Thermo Fisher Scientific10270106
青霉素-链霉素 (PenStrep)BioConcept4-01F00-H
NE-PER 细胞核和细胞质提取试剂Thermo Fisher Scientific78833
1,4-二硫苏糖醇 (DTT)Carl Roth6908.3
Dynabeads 蛋白 GNovex,Thermo Fisher Scientific10003D
DRBP76 (NF90/NF110) 抗体BD 转导实验室612154WB 使用 1:1,000,ICC/PLA RBM3 抗体使用 1:1,000 和 1:100
Protein Tech14363-1-APWB 使用 1:1,000,ICC/PLA
Lamin A/C 抗体Cell Signaling Technology#2032WB 使用 1:1,000 
抗 GAPDH 抗体Abcamab8245对 WB 使用 1:1,000
正常兔 IgGSanta Cruzsc-2027
抗兔 IgG,HRP 连接的二抗Cell Signaling Technology#7074对 WB 使用 1:5,000 的比例。
抗小鼠 HRP 二抗Carl Roth4759.1对 WB 使用 1:5,000 的比例 
Clarity Western ECL 印迹底物Bio-Rad#1705060
NuPAGE Novex 4-12% Bis-Tris 凝胶Novex、Thermo Fisher ScientificNP0321BOX
NuPAGE LDS 样品缓冲液 (4x)Novex、Thermo Fisher ScientificNP0007
NuPAGE MES SDS 电泳缓冲液 (20x)Novex、Thermo Fisher ScientificNP0002
NuPAGE 转印缓冲液 (20x)Novex、Thermo Fisher ScientificNP00061
Amersham Hypond P 0.2 PVDF 膜GE Healthcare 生命科学10600021
聚-D-赖氨酸 8 孔培养玻片康宁 BioCoat354632
多聚甲醛 (PFA)SigmaP6148
正常山羊血清 (NGS)Gibco、Thermo Fisher ScientificPCN5000
山羊抗小鼠 IgG(H+L 抗体)、Alexa Fluor 488 偶联物Thermo Fisher ScientificA-11001
山羊抗兔 IgG(H+L 抗体)、Alexa Fluor 568 偶联物Thermo Fisher ScientificA-11011
4′、6-二脒-2-苯基吲铚 (DAPI)SigmaD9542
Duolink PLA 探针 抗小鼠 PLUSSigmaDUO92001
Duolink PLA 探针 抗兔 MINUSSigmaDUO92005
Duolink 检测试剂 RedSigmaDUO92008
Duolink 洗涤缓冲液 荧光SigmaDUO82049
Duolink 封固剂,含 DAPISigma DUO82040
Mowiol 4-88Sigma81381
显微镜OlympusAX-70
CCD照相机SPOTInsight 2MP Firewire
X射线胶片富士SuperRX
胶片冲洗机富士FPM-100A

参考文献

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Patiño, C., Haenni, A. L., Urcuqui-Inchima, S. NF90 isoforms, a new family of cellular proteins involved in viral replication? Biochimie. 108, 20-24 (2015).
  2. Shim, J., Lim, H., R Yates, J., Karin, M. Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol Cell. 10 (6), 1331-1344 (2002).
  3. Sakamoto, S., et al. The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway. Mol Cell Biol. 29 (13), 3754-3769 (2009).
  4. Dresios, J., et al. Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis. Proc Natl Acad Sci. 102 (6), 1865-1870 (2005).
  5. Danno, S., Itoh, K., Matsuda, T., Fujita, J. Decreased expression of mouse Rbm3, a cold-shock protein, in Sertoli cells of cryptorchid testis. Am J Pathol. 156 (5), 1685-1692 (2000).
  6. Wellmann, S., et al. Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. J Cell Sci. 117 (Pt 9), 1785-1794 (2004).
  7. Zhu, X., Zelmer, A., Kapfhammer, J. P., Wellmann, S. Cold-inducible RBM3 inhibits PERK phosphorylation through cooperation with NF90 to protect cells from endoplasmic reticulum stress. FASEB J. 30 (2), 624-634 (2016).
  8. Fields, S., Song, O. A novel genetic system to detect protein-protein interactions. Nature. 340 (6230), 245-246 (1989).
  9. Verhelst, J., De Vlieger, D., Saelens, X. Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein. J Vis Exp. (98), (2015).
  10. Söderberg, O., et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 3 (12), 995-1000 (2007).
  11. Jarvius, M., et al. In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method. Mol Cell Proteomics. 6 (9), 1500-1509 (2007).
  12. Liu, C. H., et al. Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma. Mol Cell Proteomics. 12 (5), 1335-1349 (2013).

访问受限。请登录或开始试用以查看此内容。

重印与许可

申请许可以重复使用本 JoVE 文章的文本或图表

申请许可

标签

HEK293 NF90 RBM3

相关文章